With the analysis among 1,031 patents, we discovered top 194 key players by total patent application. Bristol Myers Squibb Co., Pfizer Products, Inc., Pfizer Inc. are dominant in this area. They take 15.32% of the total patent filing.
New York, United States
Patent: 59
Connecticut, United States
Patent: 57
New York, United States
Patent: 42
Glenmark Pharmaceuticals SA
Neuchâtel, Switzerland
Patent: 41
Indiana, United States
Patent: 37
Aegerion Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 33
Kissei Pharmaceutical Co., Ltd.
Nagano-ken, Japan
Patent: 32
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 30
Basel-Stadt, Switzerland
Patent: 27
Aichi-ken, Japan
Patent: 27
With the analysis among 12 patents, we discovered top 3 start-ups by total patent application.
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 4
Institut National de la Santé et de la Recherche Médicale
With the analysis among related 118 patents applied in the last 5 years. We discover 56 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Zymtronix Catalytic Systems, Inc., Chengdu Hyperway Pharmaceuticals Co., Ltd. take 11.86% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 5
Zymtronix Catalytic Systems, Inc.
New York, United States
Patent: 5
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 4
Shenzhen Haibowei Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 4
Gyeonggi-do, South Korea
Patent: 3
Macau University of Science & Technology
Macao SAR, China
Patent: 3
Indiana, United States
Patent: 3
Ningbo Kangbairuige Pharmaceutical Technology Co Ltd
Zhejiang Sheng, China
Patent: 2
Anling Biomedical (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 2
With the analysis among related 118 patents in last 5 years, we discover 40 new entrants. Zymtronix Catalytic Systems, Inc., Chengdu Hyperway Pharmaceuticals Co., Ltd., Shenzhen Haibowei Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Zymtronix Catalytic Systems, Inc.
New York, United States
Patent: 5
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 4
Shenzhen Haibowei Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 4
Macau University of Science & Technology
Macao SAR, China
Patent: 3
Ningbo Kangbairuige Pharmaceutical Technology Co Ltd
Zhejiang Sheng, China
Patent: 2
Maharashtra, India
Patent: 2
Xinjiang Uygur Zizhiqu, China
Patent: 2
Anling Biomedical (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Anhui Tongjisheng Biotechnology Co., Ltd.
Anhui Sheng, China
Patent: 2
Hangzhou Normal University
Zhejiang Sheng, China
Patent: 2
With the analysis among 201 patents, we discovered top 48 universities and scientific research institutions by total patent application. University of British Columbia, Queen Mary University of London, Eberhard Karls Universität Tübingen are dominant in this area. They take 12.44% of the total patent filing.
University of British Columbia
British Columbia, Canada
Patent: 7
Queen Mary University of London
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 6
Baden-Württemberg, Germany
Patent: 4
Shanghai Second Medical University
Oklahoma State University
Oklahoma, United States
Patent: 3
Jilin Sheng, China
Patent: 3
Zhejiang Sheng, China
Patent: 3
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 3
Korea Institute of Science & Technology